A business in context

TCRX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-13 · 0001193125-26-424198 · Items 5.02

  2. 4 · Ownership change

    Report date 2026-10-01 · 0001193125-26-412521

  3. 4 · Ownership change

    Report date 2026-10-01 · 0001193125-26-412518

  4. 8-K · Current report

    Report date 2026-09-24 · 0001193125-26-409199 · Items 5.02

  5. 8-K · Current report

    Report date 2026-09-08 · 0001193125-26-388631 · Items 5.02

  6. 8-K · Current report

    Report date 2026-08-27 · 0001193125-26-379343 · Items 2.05,3.01,5.02,7.01,8.01,9.01

  7. 8-K · Current report

    Report date 2026-08-12 · 0001193125-26-355664 · Items 1.02

  8. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-345749

  9. 8-K · Current report

    Report date 2026-08-12 · 0001193125-26-345732 · Items 2.02,9.01

  10. 8-K · Current report

    Report date 2026-06-22 · 0001193125-26-276693 · Items 7.01,8.01,9.01

  11. 4 · Ownership change

    Report date 2026-05-20 · 0001193125-26-236870

  12. 8-K · Current report

    Report date 2026-05-20 · 0001193125-26-236862 · Items 5.03,5.07,9.01

  13. 4 · Ownership change

    Report date 2026-05-20 · 0001193125-26-236855

  14. 4 · Ownership change

    Report date 2026-05-20 · 0001193125-26-236854

  15. 4 · Ownership change

    Report date 2026-05-20 · 0001193125-26-236848

  16. 4 · Ownership change

    Report date 2026-05-20 · 0001193125-26-236844

  17. 4 · Ownership change

    Report date 2026-05-20 · 0001193125-26-236841

  18. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-207572

  19. 8-K · Current report

    Report date 2026-05-06 · 0001193125-26-207549 · Items 2.02,9.01

  20. DEF 14A · Proxy statement

    Report date 2026-05-20 · 0001193125-26-160304

  21. 8-K · Current report

    Report date 2026-03-31 · 0001193125-26-138973 · Items 5.02

  22. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-089884

  23. 8-K · Current report

    Report date 2026-03-04 · 0001193125-26-089871 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2026-01-12 · 0001193125-26-009771 · Items 7.01,9.01

  25. 8-K · Current report

    Report date 2025-11-25 · 0001193125-25-300538 · Items 5.02

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-275933

  27. 8-K · Current report

    Report date 2025-11-12 · 0001193125-25-275889 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-11-03 · 0001193125-25-261612 · Items 2.05,7.01,8.01,9.01

  29. 8-K · Current report

    Report date 2025-09-09 · 0001193125-25-198768 · Items 7.01,9.01

  30. 8-K · Current report

    Report date 2025-08-14 · 0001193125-25-184083 · Items 5.02

  31. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-106919

  32. 8-K · Current report

    Report date 2025-08-12 · 0000950170-25-106915 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2025-06-30 · 0001193125-25-154336 · Items 5.07

  34. DEF 14A · Proxy statement

    Report date 2025-06-30 · 0001193125-25-119378

  35. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-063968

  36. 8-K · Current report

    Report date 2025-05-06 · 0000950170-25-063959 · Items 2.02,9.01

  37. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-033077

  38. 8-K · Current report

    Report date 2025-03-05 · 0000950170-25-033071 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2024-12-26 · 0001193125-24-284671 · Items 1.01,8.01,9.01

  40. 8-K · Current report

    Report date 2024-12-20 · 0001193125-24-283673 · Items 1.01,1.02,2.03,7.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001783328TScan Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$2.82M$3.02M
    2023-12-31$21.05M$23.27M
    2022-12-31$13.54M$15.58M
    2021-12-31$10.14M$12.61M
    2020-12-31$1.08M$1.41M

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗